Clinical Trials Directory

Trials / Completed

CompletedNCT05444140

A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk

A Theory-guided Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk to Improve Health Promoting Behaviours: a Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
40 Years – 64 Years
Healthy volunteers
Accepted

Summary

Cardiometabolic disease has been an increasing trend globally and remains the major cause of morbidity and mortality. Health coaching, a process of goal-oriented and client-centered partnership that is health-focus and through client enlightenment and empowerment, are generally effective for chronic disease management and prevention of complication. However, there is inconclusive result on the effects of health coaching in the primary prevention of cardiometabolic diseases. Therefore, this study aimed to assess the feasibility and acceptability of a theory-guided health coaching programme for middle-aged adults with cardiometabolic risk.

Detailed description

A single group pretest-posttest feasibility study was conducted. The health coaching programme included four monthly health coaching sessions for three months. Feasibility of the study was measured by eligibility rate, enrollment rate, adherence rate, and attrition rate. Intervention acceptability was measured by satisfactory survey after completion of health coaching intervention. Feasibility of outcome measures was measured by the completion of outcome measures assessment at baseline and 6 months after enrollment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHealth coachingThe health coaching programme includes four monthly health coaching sessions for three months.

Timeline

Start date
2021-04-01
Primary completion
2021-11-13
Completion
2021-11-13
First posted
2022-07-05
Last updated
2022-07-05

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05444140. Inclusion in this directory is not an endorsement.